LEVELS ANTIINFAMMATORY CYTOKINES (ІL-4, ІL-10) IN MAINTENCE HEMODIALYSIS PATIENTS DEPENDING ON EXPRESSED ANAEMIA AND CHARACTER DEFEAT OF KIDNEY
Abstract
Aims: The purpose of the present study was to compare the levels of anti-inflammatory cytokines in patients with chronic kidney disease, prolonged sessions of hemodialysis, depending on the severity of anemia.
Materials and methods: We investigated 155 patients with chronic kidney disease, prolonged sessions of hemodialysis and anemia (mean age 46.4±12.4). Patients were divided into 4 groups depending on expressed of anemia: in the I-st (n=22) group – patients with the level of hemoglobin over 110g/l, in the II (n=66) group hemoglobin 90 - 110g/l, in the III (n=44) group hemoglobin 70-89 g/l, in the IV (n=22) group hemoglobin <70 g/l.
Results: We have defined that level of IL-4 was clinically significantly lower (p <0.001) in patients, who have getting hemodialysis by comparison to control group. Levels of IL-4 had a significant differences between all of group of patients and controls (p <0.05). IL-10 had a positive correlation with the level of Hb (r=0.2405; p=0.003). ІL-4 had a negative correlation with the level of Hb (r=-0.4842; p <0.001).
The average level of IL-4 was significantly increased in diabetic patients compared with non-diabetic patients 92±17.7 vs 48.3±28.1 (p <0.05).
Conclusions: All of studied patients have had an increased level of anti- inflammatory cytokines. Serum IL-4 was higher in patients with diabetes. The levels of anti-inflammatory cytokines (IL-4 and IL-10) have had a significant correlation with the severity of anemia.
Downloads
References
Імовірність розвитку цитокін-медійованого анемічного синдрому у хворих на ревматоїдний артрит / В. Н. Коваленко та ін. // Український ревматологічний журнал. – 2010. – № 2. – С. 33-40.
Christopher W. Inflammation cytokines and chemokines in chronic kidney disease / W. Christopher // The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. – 2009. – Vol. 20 (1). – P 320- 325.
Girndt M. Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients / M. Girndt Nephrol Dial Transplant. – 2007. – Vol. 22. – P. 3586-3592.
Girndt M. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk / M. Girndt, H. KoЁhler // Nephrol DiaTransplant. – 2003. – Vol. 18. – P. 1976-1979.
Importance of Ferritin for Optimizing Anemia Therapy in Chronic Kidney Disease / Takeshi Nakanishi at all. // Am J Nephrol – 2010. – Vol. 32. – Р. 439-446.
Increased Expression of Erythropoiesis Inhibiting Cytokines (IFN-γ, TNF-α, IL-10, and IL-13) by T Cells in Patients Exhibiting a Poor Response to Erythropoietin Therapy / Angela C. Cooper at all. // JASN – 2003. – Vol. 14 (7). – P. 1776-1784.
Role of IL-10 for Induction of Anemia During Inflammation / H. Tilg at all. // J Immunol. – 2002. – Vol. 169 (4) – P. 2204-2209.
